Esogel 40 mg/vial (IV Injection)
40 mg vial: ৳ 90.00
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Novatek pharmaceuticals ltd |
Also available as |
Indications
- Relief from chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection
- Zollinger-Ellison Syndrome
- Acid-related Dyspepsia
- Duodenal & Gastric ulcer
Pharmacology
- Proton pump inhibitor
- Suppression of gastric acid secretion
- Absorption dynamics
- Distribution in plasma proteins
- Metabolism by CYP enzymes
- Excretion details
- Combination therapy with antimicrobials
Dosage
- Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks
- Maintenance of Healing of Erosive Esophagitis: 20 mg Once Daily
- Symptomatic GERD: 20 mg Once Daily for 4 Weeks
- Helicobacter Pylori eradication: Triple Therapy
- Zollinger-Ellison Syndrome: 20-80 mg once daily
- Acid-related Dyspepsia: 20-40 mg once daily
- Duodenal ulcer: 20 mg once daily
- IV Injection: Dosage by patient's age and condition
Administration
- Tablet or capsule should be swallowed whole and taken one hour before a meal
- Oral Suspension
- IV Injection
- IV Infusion
Interaction
- Extensive metabolism in the liver by CYP2C19 and CYP3A4
- Potential interference with CYP2C19
- Inhibition of gastric acid secretion affecting drug absorption
- Specific interactions with certain drugs
Contraindications
- Known hypersensitivity to any of the formulations
Side Effects
- Headache
- Diarrhea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Animal studies revealed no teratogenic effects
- Excretion in milk not studied
- Breastfeeding should be discontinued if essential
Precautions & Warnings
- Symptomatic response does not preclude the presence of gastric malignancy
- Detailed instructions for patients with swallowing difficulty
- Use of antacids while taking Esogel
Use in Special Populations
- Safety and effectiveness in paediatric patients not established
- No overall differences in safety and efficacy in the elderly
- Dosage adjustment recommendations for hepatic insufficiency
- Expected pharmacokinetics in renal impairment
Overdose Effects
- Toxicity signs in animal studies
- No specific antidote known
- Symptomatic and supportive treatment recommended
Storage Conditions
- Temperature and environmental storage instructions
Chemical Structure
- Molecular Formula: C17H19N3O3S
- Chemical Structure Image
Common Questions
- Uses and working mechanism of Esogel 40 mg/vial Injection
- Common side effects
- Safety concerns during pregnancy and breastfeeding
- Onset of action
- Quick tips for dosage and precautions
Related Brands
- Espazole 20 mg (Capsule (Enteric Coated)) - arges-life-science-limited
- Esoprol 40 mg/vial (IV Injection) - ziska-pharmaceuticals-ltd
- E-Proton 40 mg (Capsule (Enteric Coated)) - doctor-tims-pharmaceuticals-ltd
- E-Proton 20 mg (Capsule (Enteric Coated)) - doctor-tims-pharmaceuticals-ltd
- Raceper 20 mg (Tablet (Enteric Coated)) - al-madina-pharmaceuticals-ltd